Home / Expertise / Life Sciences & Healthcare
side view of scientist looking into microscope in bright research lab

Life Sciences & Healthcare

Russia

With over 150 international specialist lawyers across CMS and the support of the Lifesciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your life sciences & healthcare business. We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the life sciences & healthcare sector. We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice. Equally, when you need life sciences & healthcare specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Read more Read less

Feed

Show only
13 July 2020
CMS suc­cess­fully de­fen­ded GE Health­care in a court case against the Rus­si­an...
CMS has suc­cess­fully rep­res­en­ted in­terests of GE Health­care in sev­er­al court pro­ceed­ings against the Rus­si­an health­care reg­u­lat­ory au­thor­ity (Roszdravn­ad­zor)
20 April 2020
CMS Ex­pert Guide to ad­vert­ising of medi­cines and med­ic­al devices
Are you look­ing for in­form­a­tion on phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising? Learn more about it in this CMS Ex­pert Guide.
21 July 2020
Rus­sia re­mains set on im­port sub­sti­tu­tion for state-pro­cured goods
The ex­ist­ing ban on the state pro­cure­ment of for­eign in­dus­tri­al goods has been gen­er­al­ised un­der a Rus­si­an Gov­ern­ment De­cree* which came in­to force on 1 May 2020. For cer­tain groups of goods to be ad­mit­ted...
04 June 2020
CMS Rus­sia earns 58 re­cog­ni­tions by Best Law­yers 2021
26 CMS Rus­sia ex­perts have been se­lec­ted for in­clu­sion in­to the 2021 edi­tion of the Best Law­yers. In total, we have earned 58 re­cog­ni­tions by the rank­ing.
20 April 2020
CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
Are you look­ing for in­form­a­tion on can­nabis law and le­gis­la­tion? This CMS Ex­pert Guide provides you with everything you need to know.
15 July 2020
Will rates in double tax­a­tion treat­ies in­crease in the near fu­ture?
There are cur­rently mul­tiple ini­ti­at­ives re­gard­ing the in­crease in rates for taxes re­tained at source un­der double tax­a­tion treat­ies (“DTTs”) between the Rus­si­an Fed­er­a­tion and some for­eign jur­is­dic­tions....
12 March 2020
CMS Rus­sia keeps its strong po­s­i­tions in Cham­bers Europe 2020
“They have both very strong tech­nic­al skills and busi­ness know­ledge”, says a cli­ent about CMS Rus­sia that was ranked by Cham­bers Europe 2020
08 July 2020
“WIPO PROOF”: WIPO’s new on­line ser­vice which helps in­nov­at­ors and cre­at­ors...
The World In­tel­lec­tu­al Prop­erty Or­gan­isa­tion (WIPO) re­cently launched its new on­line busi­ness ser­vice, “WIPO PROOF”. The plat­form aims to help in­nov­at­ors and cre­at­ors safe­guard their in­tel­lec­tu­al...
14 February 2020
CMS Rus­sia ac­com­plishes strong show­ing in Cham­bers Glob­al 2020
CMS Rus­sia has been ranked by Cham­bers Glob­al 2020.
02 July 2020
Bank of Rus­sia sim­pli­fies pro­ced­ures for is­su­ing se­cur­it­ies and dis­clos­ing...
On 11 May 2020, a new Bank of Rus­sia Reg­u­la­tion* “On Stand­ards for the Is­su­ance of Se­cur­it­ies” (the “Reg­u­la­tion on Is­su­ance Stand­ards”) came in­to force. The reg­u­lat­or up­dated this Reg­u­la­tion in...
28 October 2019
Do­ing busi­ness in Rus­sia 2019
26 May 2020
European Com­mis­sion must ad­dress in­tel­lec­tu­al prop­erty and AI
The Com­mit­tee on Leg­al Af­fairs (JURI) of the European Par­lia­ment has pub­lished three draft re­ports re­lat­ing to ar­ti­fi­cial in­tel­li­gence (AI). This note is about the draft re­port on in­tel­lec­tu­al prop­erty...